Dasatinib (active substance) - analogs
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
| Prices in pharmacies: Instructions Dasatinib | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Dasatinib included in the composition |
Prices in pharmacies |
| Sprycel | 1388.4€ |
| Dasatinib-nativ | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 75% Bosutinib
- 71% Imatinib
- 63% Tioguanine
- 57% Akalabrutinib
- 53% Amsacrine
- 51% Mercaptopurine
- 46% Ibrutinib
- 45% Nilotinib
- 45% Nelarabine
- 44% Inotuzumab ozogamicin
- 40% Prodimin
- 40% Venetoclax
- 37% Chlorethylaminouracil
- 37% Pegaspargase
- 35% Cytarabine
- 32% Fludarabine
- 32% Blinatumomab
- 32% Paphencyl
- 29% Dipin
- 29% Idarubicin
- 27% Abemaciclib
- 27% Ixazomib
- 27% Lipegfilgrastim
- 27% Palbociclib
- 27% Sorafenib
- 26% Trametinib
- 26% Cabozantinib
- 25% Asparaginase
- 25% Obinutuzumab
- 25% Ofatumumab
- 25% Hexaphosphamide
- 25% Vandetanib
- 24% Lorlatinib
- 24% Pazopanib
- 24% Midostaurin
- 23% Lophenalac
- 23% Osimertinib
- 23% Ribociklib
- 23% Ceritinib
- 23% Busulfan
- 23% Afatinib
- 23% Daunorubicin
- 21% Nintedanib
- 20% Hydroxycarbamide
- 20% Crizotinib
- 19% Lenograstim
- 18% Vemurafenib
- 18% Pumitepa
- 18% Rufocromomycin
- 18% Dabrafenib
Learn more about the selection of analogues
- The drug has «Dasatinib» 51 analog by action, the most similar - Bosutinib .
- Medical online service has selected the best substitutes for Dasatinib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Dasatinib to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.